Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2016 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.
Wang K, Saniei S, Poddar N, Autar S, Carcamo S, Sreenath M, Peplinski JH, Ries RE, Martinez IG, Chao C, Mei AH, Rahman N, Mekerishvili L, Quijada-Álamo M, Freed G, Zhang M, Lachman K, Diaz Z, Gonzalez MM, Zhang J, Pham G, Filipescu D, Berisa M, Balestra T, Reisz JA, D'Alessandro A, Puleston DJ, Bernstein E, Chipuk JE, Wunderlich M, Tasian SK, Marcellino BK, Glass IA; BDRL; Sturgeon CM, Landau DA, Chen Z, Papapetrou EP, Izzo F, Meshinchi S, Hasson D, Wagenblast E. Wang K, et al. Among authors: autar s. bioRxiv [Preprint]. 2025 Mar 20:2025.03.19.643917. doi: 10.1101/2025.03.19.643917. bioRxiv. 2025. PMID: 40166161 Free PMC article. Preprint.
Improved adipose tissue function with initiation of protease inhibitor-only ART.
Maughan RT, Feeney ER, Capel E, Capeau J, Domingo P, Giralt M, Lange JM, Phanuphak P, Cooper DA, Reiss P, Mallon PW; HIVNAT-019 Study Group. Maughan RT, et al. J Antimicrob Chemother. 2016 Nov;71(11):3212-3221. doi: 10.1093/jac/dkw301. Epub 2016 Aug 11. J Antimicrob Chemother. 2016. PMID: 27516476 Free PMC article. Clinical Trial.
Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response.
Young-Sharma T, Lane CR, James R, Wilmot M, Autar S, Hui K, Strobel AG, Lacey JA, Kumar S, Datt A, Lata A, Cameron D, Sherry NL, Genaro S, Ditukana T, Nabose I, Goneyali A, Bennett E, Kavoa A, Prasad S, Vakamocea A, Suka A, Prasad P, Hussein F, Lin C, Jenney AW, Buising K, Naidu R, Howden BP. Young-Sharma T, et al. Among authors: autar s. Lancet Reg Health West Pac. 2024 Nov 20;53:101234. doi: 10.1016/j.lanwpc.2024.101234. eCollection 2024 Dec. Lancet Reg Health West Pac. 2024. PMID: 39633714 Free PMC article.
Establishing carbapenem resistant organism surveillance, prevention, and control in a middle-income country: implementation of a hospital-based program in Fiji.
Getahun Strobel A, Kumar SS, Prasad S, Young-Sharma T, Richards M, Datt A, Lata A, Genaro SA, Ratusela T, Nabose I, Vakamocea A, Autar S, Hussein F, Naidu R, Suka A, Cameron D, Lin C, Lane CR, Macintyre A, Hui K, James R, Kennedy B, Howden BP, Buising K. Getahun Strobel A, et al. Among authors: autar s. Antimicrob Resist Infect Control. 2025 Mar 5;14(1):19. doi: 10.1186/s13756-025-01534-5. Antimicrob Resist Infect Control. 2025. PMID: 40038841 Free PMC article.
The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019-2022.
Getahun Strobel A, Prasad P, Lane CR, Naidu R, Autar S, Young-Sharma T, Richards M, Suka A, Cameron D, James R, Prasad R, Buising K, Howden BP, Prasad V. Getahun Strobel A, et al. Among authors: autar s. Lancet Reg Health West Pac. 2024 Mar 14;45:101036. doi: 10.1016/j.lanwpc.2024.101036. eCollection 2024 Apr. Lancet Reg Health West Pac. 2024. PMID: 38516290 Free PMC article.
Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227.
Ruxrungtham K, Pedro RJ, Latiff GH, Conradie F, Domingo P, Lupo S, Pumpradit W, Vingerhoets JH, Peeters M, Peeters I, Kakuda TN, De Smedt G, Woodfall B; TMC125-C227 study group. Ruxrungtham K, et al. HIV Med. 2008 Nov;9(10):883-96. doi: 10.1111/j.1468-1293.2008.00644.x. Epub 2008 Sep 14. HIV Med. 2008. PMID: 18795960 Free article. Clinical Trial.